Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome.

about

Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome.

Item

http://www.wikidata.org/entity/Q35598864

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome.

@ast

Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome.

@en

type

Item

label

Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome.

@ast

Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome.

@en

prefLabel

Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome.

@ast

Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome.

@en

P1476

Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome.

@en

P2093

Bassel Nazha

http://www.w3.org/2001/XMLSchema#string

Gwenalyn Garcia

http://www.w3.org/2001/XMLSchema#string

Marcel Odaimi

http://www.w3.org/2001/XMLSchema#string

Ruben Kandov

http://www.w3.org/2001/XMLSchema#string

P2860

Development of acute myocardial infarction in a young female patient with essential thrombocythemia treated with anagrelide: a case report

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia

Somatic mutations of calreticulin in myeloproliferative neoplasms.

Non ST-segment elevation myocardial infarction in patient with essential thrombocythemia.

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.

Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia.

Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction.

Essential thrombocythemia: a case of acute ST-segment elevation myocardial infarction in a young female.

[Development of acute coronary syndrome in three patients with essential thrombocythemia or polycythemia vera].

P304

161764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/161764

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276161082

http://www.w3.org/2001/XMLSchema#string

P698

26064712

http://www.w3.org/2001/XMLSchema#string

P932

4429202

http://www.w3.org/2001/XMLSchema#string